Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
1.
Mol Cell Endocrinol ; 414: 156-67, 2015 Oct 15.
Article in English | MEDLINE | ID: mdl-26210066

ABSTRACT

Salt inducible kinase 1 (SIK1) has been reported to repress cAMP-response element binding protein (CREB)-mediated gene transcription by causing the nuclear export of CREB-regulated transcription coactivators (CRTCs) through phosphorylation. Although the repressor role of SIK1 in suppressing the expression of arylalkylamine N-acetyltransferase, the enzyme that controls the daily rhythm in melatonin production in the rat pineal gland, has been established, whether SIK1 regulates the phosphorylation and localization of CRTC1 and CRTC2 in this tissue remains unclear. The present study found that overexpressing SIK1 in NE-stimulated rat pinealocytes could increase the phosphorylation of CRTC1 and CRTC2, reduced selectively the nuclear level of CRTC2 (but not that of CRTC1), and elevated the cytosolic levels of both CRTC1 and CRTC2. In contrast, transient knockdown of endogenous SIK1 had no effect on the phosphorylation or distribution of CRTC1 and CRTC2 in norepinephrine (NE)-stimulated pinealocytes. Our results also showed that adrenergic blockade during NE stimulation led to a rapid rephosphorylation and decline in the nucleus levels of CRTC1 and CRTC2; however SIK1 knockdown had no effect on this rapid rephosphorylation. Moreover, studies with kinase inhibitors revealed that kinase(s) sensitive to KT5823 appeared to be involved in this rapid rephosphorylation. Together, these results indicate that although overexpressing SIK1 can phosphorylate CRTC1 and CRTC2 in the NE-stimulated pinealocyte, the endogenous SIK1, in spite of its induction by NE, does not appear to be the main regulator of the phosphorylation and intracellular localization of these two coactivators.


Subject(s)
Adrenergic alpha-Agonists/pharmacology , Norepinephrine/pharmacology , Pineal Gland/drug effects , Protein Serine-Threonine Kinases/metabolism , Trans-Activators/metabolism , Transcription Factors/metabolism , Animals , Cell Nucleus/drug effects , Cell Nucleus/genetics , Cell Nucleus/metabolism , Cells, Cultured , Cytosol/drug effects , Cytosol/metabolism , Gene Expression Regulation/drug effects , Male , Phosphorylation/drug effects , Pineal Gland/cytology , Pineal Gland/metabolism , Protein Serine-Threonine Kinases/genetics , Rats , Trans-Activators/genetics , Transcription Factors/genetics
2.
Diabet Med ; 32(2): 164-73, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25407209

ABSTRACT

AIMS: To examine the association between gestational diabetes mellitus (GDM) and high maternal weight and the risk of development of chronic disease. METHODS: Women with singleton deliveries between April 1999 and March 2010 in Alberta, Canada, were categorized according to pre-pregnancy weight (overweight ≥ 91 kg) and GDM status. Obstetric and neonatal outcomes, as well as the long-term incidence of maternal diabetes, hypertension and cardiovascular disease were examined. RESULTS: Of 240 083 women, 213 765 (89%) had no GDM and were not overweight (reference group), 17 587 (7.3%) were overweight only, 7332 (3%) had GDM only and 1399 (0.6%) had GDM and were overweight. Significant differences in Caesarean section rates, induction rates and birthweight were observed across the four groups. During a median follow-up of 5.3 years, diabetes incidence was 36% in the GDM and overweight, 18.8% in the GDM only, 4.8% in the overweight only and 1.1% in the reference group. With respect to hypertension and cardiovascular disease, the GDM and overweight group had the highest rates (26.8% and 3.1%, respectively) and the reference group had the lowest rates (5.8% and 1.0%, respectively). However, rates were similar in the GDM only (14.9% and 1.9%, respectively) and overweight only groups (14.9% and 1.5%, respectively). CONCLUSIONS: Not surprisingly, the presence of both high maternal weight and GDM compounds the risk of developing diabetes. However, the association between overweight alone and GDM alone and hypertension and cardiovascular disease appears similar suggesting a need for effective interventions to manage both these conditions to improve the health of these patients.


Subject(s)
Cardiovascular Diseases/etiology , Diabetes Mellitus/etiology , Diabetes, Gestational/physiopathology , Hypertension/etiology , Maternal Nutritional Physiological Phenomena , Overweight/physiopathology , Pregnancy Complications/physiopathology , Adolescent , Adult , Alberta/epidemiology , Cardiovascular Diseases/epidemiology , Cohort Studies , Cross-Sectional Studies , Diabetes Mellitus/epidemiology , Female , Humans , Hypertension/epidemiology , Incidence , Longitudinal Studies , Middle Aged , Overweight/complications , Pregnancy , Registries , Retrospective Studies , Risk Factors , Young Adult
3.
Endocrinology ; 154(9): 3240-50, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23751872

ABSTRACT

The process involved in relocation of the coactivator, transducer of regulated cAMP-regulated element-binding protein (TORC) to the cytoplasm, unlike its activation, is not well understood. Using cultured pineal cells prepared from male rats, we found that although both α- and ß-adrenergic stimulation could cause TORC1 dephosphorylation, only α-adrenergic stimulation was effective in the norepinephrine (NE)-mediated translocation of TORC1 into the nucleus. In contrast, blockade of either the α- or the ß-adrenergic receptor after NE stimulation was effective in causing the rephosphorylation and rapid relocation of TORC1 into the cytoplasm. Studies with phosphoprotein phosphatase (PP) inhibitors indicated that although both PP2A and PP2B could dephosphorylate TORC1, only PP2B could cause translocation into the nucleus. However, after NE stimulation, treatment with either PP2A or PP2B inhibitors could cause the rephosphorylation and cytoplasmic relocation of TORC1. These results indicate a requirement of continuous activation of both α- and ß-adrenergic receptors as well as PP2A and PP2B activities for the nuclear retention of TORC1 during NE stimulation. Knockdown of salt-inducible kinase 1 (SIK1) had no effect on the phosphorylation or localization of TORC1. Although overexpressing SIK1 could induce TORC1 phosphorylation in the nucleus, it did not reduce TORC1 level in the nucleus, indicating that SIK1-mediated TORC1 phosphorylation may not be sufficient for its relocation into the cytoplasm. Together, these results demonstrate that, in the rat pineal gland, different mechanisms are involved in regulating the nuclear entry and exit of TORC1 and that the SIK1-mediated phosphorylation of TORC1 may not lead to its nuclear exit.


Subject(s)
Cell Nucleus/metabolism , Multiprotein Complexes/metabolism , Neuroendocrine Cells/metabolism , Norepinephrine/metabolism , Pineal Gland/metabolism , Receptors, Adrenergic, alpha/metabolism , Receptors, Adrenergic, beta/metabolism , TOR Serine-Threonine Kinases/metabolism , Adrenergic Agonists/pharmacology , Adrenergic Antagonists/pharmacology , Animals , Biological Transport/drug effects , Cell Nucleus/drug effects , Cells, Cultured , Cytoplasm/drug effects , Cytoplasm/metabolism , Enzyme Inhibitors/pharmacology , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Male , Mechanistic Target of Rapamycin Complex 1 , Nerve Tissue Proteins/agonists , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/metabolism , Neuroendocrine Cells/cytology , Neuroendocrine Cells/drug effects , Phosphorylation/drug effects , Pineal Gland/cytology , Pineal Gland/drug effects , Protein Phosphatase 2/antagonists & inhibitors , Protein Phosphatase 2/metabolism , Protein Processing, Post-Translational/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha/chemistry , Receptors, Adrenergic, beta/chemistry
4.
Diabet Med ; 30(8): 977-85, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23601039

ABSTRACT

BACKGROUND: Although allergic reactions to insulin are uncommon, they can be difficult to diagnose and management may be very difficult in subjects with Type 1 diabetes with severe allergy. Access to allergists and specialist diagnostic tests is limited and few diabetes specialists are familiar with desensitization as a means of treating allergy. People with diabetes may develop symptoms which mimic insulin allergy but are attributable to other conditions. CASE REPORTS: Here we describe three cases of insulin allergy. One patient presented with severe, albeit localized, urticarial reactions at injection sites. The most severe case was a woman with recent-onset Type 1 diabetes who presented with grade 2 anaphylaxis. The third patient presented with generalized urticaria and angioedema. Insulin allergy was confirmed in all three cases. METHODS: Assessment involved measurement of immunoglobulin and anti-insulin antibody levels. Skin testing was performed in two cases. Treatments included desensitization in one case, alternative insulin preparations, antihistamines and continuous subcutaneous insulin infusion. In all three cases of insulin allergy there has been successful resolution of symptoms. CONCLUSIONS: The clinical assessment and investigation in cases of suspected insulin allergy is described, along with detailed algorithms for skin testing and desensitization. This case series demonstrates an approach to challenging cases of suspected insulin allergy which will be helpful for diabetes specialists.


Subject(s)
Drug Hypersensitivity/diagnosis , Hypoglycemic Agents/adverse effects , Insulin/adverse effects , Adult , Aged , Anaphylaxis/etiology , Anaphylaxis/prevention & control , Angioedema/etiology , Angioedema/prevention & control , Desensitization, Immunologic , Diabetes Mellitus/drug therapy , Diabetes Mellitus/immunology , Drug Eruptions/diagnosis , Drug Eruptions/immunology , Drug Eruptions/physiopathology , Drug Eruptions/therapy , Drug Hypersensitivity/immunology , Drug Hypersensitivity/physiopathology , Drug Hypersensitivity/therapy , Drug Monitoring , Female , Humans , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Insulin/administration & dosage , Insulin/therapeutic use , Insulin Infusion Systems , Male , Middle Aged , Severity of Illness Index , Skin Tests , Treatment Outcome , Urticaria/etiology , Urticaria/prevention & control
5.
Endocrinology ; 153(8): 3839-49, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22685264

ABSTRACT

The distribution of transducers of regulated cAMP-response element-binding protein activity (TORC) between the cytoplasm and the nucleus is tightly regulated and represents one of the main mechanisms whereby the cAMP response element activation activities of TORC are controlled. Whereas both cAMP and Ca(2+) pathways can cause translocation of TORC, the relative importance of these two pathways in regulating different TORC within the same cell is unclear. In this study, we determined the mechanism that regulated TORC1 translocation and compared it with that of TORC2 in rat pinealocytes. Stimulation of pinealocytes with norepinephrine (NE), although having no effect on Torc1 transcription, caused rapid dephosphorylation of TORC1. Although NE also caused rapid dephosphorylation of TORC2, pharmacological studies revealed that TORC1 dephosphorylation could be induced by both ß-adrenoceptor/cAMP and α-adrenoceptor/intracellular Ca(2+) pathways contrasting with TORC2 dephosphorylation being induced mainly through the ß-adrenoceptor/cAMP pathway. PhosTag gel indicated a different pattern of TORC1 desphosphorylation resulting from the selective activation of α- or ß-adrenoceptors. Interestingly, only the α-adrenoceptor/intracellular Ca(2+)-mediated dephosphorylation could translocate TORC1 to the nucleus, whereas the ß-adrenoceptor/cAMP-mediated dephosphorylation of TORC1 was ineffective. In comparison, translocation of TORC2 was induced predominantly by the ß-adrenoceptor/cAMP pathway. Studies with different protein phosphatase (PP) inhibitors indicated that the NE-mediated translocation of TORC1 was blocked by cyclosporine A, a PP2B inhibitor, but that of TORC2 was blocked by okadaic acid, a PP2A inhibitor. Together these results highlight different intracellular signaling pathways that are involved in the NE-stimulated dephosphorylation and translocation of TORC1 and TORC2 in rat pinealocytes.


Subject(s)
Cell Nucleus/metabolism , Norepinephrine/pharmacology , Pineal Gland/cytology , Protein Transport/drug effects , Trans-Activators/metabolism , Transcription Factors/metabolism , Animals , Blotting, Western , Cell Nucleus/drug effects , Cells, Cultured , Male , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Trans-Activators/genetics , Transcription Factors/genetics
6.
Endocrinology ; 152(9): 3440-50, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21771889

ABSTRACT

Transducers of regulated cAMP-response element-binding protein (CREB) activity (TORC) are coactivators that can increase CREB transcriptional activity, suggesting that TORC may regulate the transcription of Aanat, a CREB-target gene. In the present study, we focused on the regulation of TORC2 and its role in Aanat transcription in the rat pineal gland. Although there was no endogenous Torc2 mRNA rhythm in the rat pineal gland and treatment of cultured pinealocytes with norepinephrine (NE) had no effect on the mRNA level of Torc2, the phosphorylation state and intracellular distribution of TORC2 protein were regulated by NE. Immunoblot analysis combined with cytosolic/nuclear fractionation or phosphatase treatment showed that TORC2 protein was rapidly dephosphorylated and translocated to the nucleus after NE stimulation in rat pinealocytes. Similar dephosphorylation of TORC2 also occurred nocturnally in the rat pineal gland. The NE-mediated TORC2 dephosphorylation was blocked by cotreatment with propranolol (a ß-adrenergic antagonist) but not prazosin (an α(1)-adrenergic antagonist) and mimicked by dibutyryl cAMP, indicating the participation of the ß-adrenergic receptor/cAMP pathway. Studies with protein phosphatase inhibitors showed that only okadaic acid and calyculin A were effective in blocking the NE-mediated TORC2 dephosphorylation, suggesting the involvement of protein phosphatase 2A in this dephosphorylation. Moreover, TORC2 overexpression had an enhancing effect on NE-stimulated Aanat transcription. Together, these results indicate that NE stimulation causes nuclear translocation of TORC2 by dephosphorylating the protein through a ß-adrenoceptor/cAMP mechanism and that nuclear localization of TORC2 appears to regulate Aanat transcription by NE in the rat pineal gland.


Subject(s)
Circadian Rhythm/physiology , Norepinephrine/metabolism , Pineal Gland/metabolism , Transcription Factors/metabolism , Adrenergic alpha-1 Receptor Antagonists/pharmacology , Adrenergic beta-Antagonists/pharmacology , Animals , Circadian Rhythm/drug effects , Cyclic AMP Response Element-Binding Protein/metabolism , Enzyme Inhibitors/pharmacology , Male , Marine Toxins , Okadaic Acid/pharmacology , Oxazoles/pharmacology , Phosphorylation/drug effects , Pineal Gland/cytology , Pineal Gland/drug effects , Prazosin/pharmacology , Propranolol/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, beta/metabolism , Signal Transduction/drug effects , Trans-Activators
7.
Endocrinology ; 150(9): 4221-30, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19470703

ABSTRACT

The recognition of the basic leucine zipper domain in the regulation of transcriptional activity of cAMP response element-binding protein by salt-inducible kinase (SIK) prompted our investigation of the regulatory role of this kinase in the induction of Aa-nat and other cAMP-regulated genes in the rat pineal gland. Here we report Sik1 expression was induced by norepinephrine (NE) in rat pinealocytes primarily through activation of beta-adrenergic receptors, with a minor contribution from activation of alpha-adrenergic receptors. Treatments with dibutyryl cAMP, and to a lesser extent, agents that elevate intracellular Ca(2+) mimicked the effect of NE on Sik1 expression. In parallel to the results of the pineal cell culture studies, a marked nocturnal induction of Sik1 transcription was found in whole-animal studies. Knockdown of Sik1 by short hairpin RNA amplified the NE-stimulated Aa-nat transcription and other adrenergic-regulated genes, including Mapk phosphatase 1, inducible cAMP repressor, and type 2 iodothyronine deiodinase in a time-dependent manner. In contrast, overexpressing Sik1 had an inhibitory effect on the NE induction of Aa-nat and other adrenergic-regulated genes. Together, our results indicate that the adrenergic induction of Sik1 in the rat pineal gland is primarily through the beta-adrenergic receptor --> protein kinase A pathway. SIK1 appears to function as part of an endogenous repressive mechanism that regulates the peak and indirectly the duration of expression of Aa-nat and other cAMP-regulated genes. These findings support a role for SIK1 in framing the temporal expression profile of Aa-nat and other adrenergic-regulated genes in the rat pineal gland.


Subject(s)
Arylalkylamine N-Acetyltransferase/biosynthesis , Pineal Gland/metabolism , Protein Serine-Threonine Kinases/physiology , Animals , Bucladesine/pharmacology , Cells, Cultured , Circadian Rhythm , Cycloheximide/pharmacology , Darkness , Dibutyryl Cyclic GMP/pharmacology , Enzyme Induction , Ionomycin/pharmacology , Male , Norepinephrine/pharmacology , Photoperiod , Pineal Gland/cytology , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha-1/physiology , Receptors, Adrenergic, beta-1/physiology , Tetradecanoylphorbol Acetate/pharmacology
8.
Endocrinology ; 150(5): 2334-41, 2009 May.
Article in English | MEDLINE | ID: mdl-19116339

ABSTRACT

We have shown previously that Ser10 phosphorylation of histone H3 occurs in rat pinealocytes after stimulation with norepinephrine (NE) and that histone modifications such as acetylation appear to play an important role in pineal gene transcription. Here we report the nocturnal phosphorylation of a Ser10 histone H3 kinase, Aurora C, in the rat pineal gland. The time profile of this phosphorylation parallels the increase in the level of phospho-Ser10 histone H3. Studies with cultured pinealocytes indicate that Aurora C phosphorylation is induced by NE and this induction can be blocked by cotreatment with propranolol or KT5720, a protein kinase A inhibitor. Moreover, only treatment with dibutyryl cAMP, but not other kinase activators, mimics the effect of NE on Aurora C phosphorylation. These results indicate that Aurora C is phosphorylated primarily by a beta-adrenergic/protein kinase A-mediated mechanism. Treatment with an Aurora C inhibitor reduces the NE-induced histone H3 phosphorylation and suppresses the NE-stimulated induction of arylalkylamine N-acetyltransferase (AA-NAT), the rhythm-controlling enzyme of melatonin synthesis, and melatonin production. The effects of Aurora C inhibitors on adrenergic-induced genes in rat pinealocytes are gene specific: inhibitory for Aa-nat and inducible cAMP repressor but stimulatory for c-fos. Together our results support a role for the NE-stimulated phosphorylation of Aurora C and the subsequent remodeling of chromatin in NE-stimulated Aa-nat transcription. This phenomenon suggests that activation of this mitotic kinase can be induced by extracellular signals to participate in the transcriptional induction of a subset of genes in the rat pineal gland.


Subject(s)
Circadian Rhythm/physiology , Histones/genetics , Histones/metabolism , Norepinephrine/pharmacology , Pineal Gland/metabolism , Protein Serine-Threonine Kinases/metabolism , Protein Serine-Threonine Kinases/physiology , Animals , Aurora Kinases , Cells, Cultured , Circadian Rhythm/genetics , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic AMP-Dependent Protein Kinases/physiology , Enzyme Activation/drug effects , Enzyme Activation/physiology , Gene Expression Regulation/drug effects , Male , Organ Specificity/drug effects , Organ Specificity/genetics , Phosphorylation/drug effects , Pineal Gland/drug effects , Protamine Kinase/metabolism , Protein Kinase Inhibitors/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/genetics , Rats , Rats, Sprague-Dawley
9.
Endocrinology ; 148(10): 4592-600, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17628002

ABSTRACT

In this study we investigated the effect of histone acetylation on the transcription of adrenergic-induced genes in rat pinealocytes. We found that treatment of pinealocytes with trichostatin A (TSA), a histone deacetylase inhibitor, caused hyperacetylation of histone H3 (H3) Lys14 at nanomolar concentrations. Hyperacetylation of H3 was also observed after treatment with scriptaid, a structurally unrelated histone deacetylase inhibitor. The effects of TSA and scriptaid were inhibitory on the adrenergic induction of arylalkylamine-n-acetyltransferase (aa-nat) mRNA, protein, and enzyme activity, and on melatonin production. TSA at higher concentrations also inhibited the adrenergic induction of mapk phosphatase-1 (mkp-1) and inducible cAMP early repressor mRNAs. In contrast, the effect of TSA on the norepinephrine induction of the c-fos mRNA was stimulatory. Moreover, the effect of TSA on adrenergic-induced gene transcription was dependent on the time of its addition; its effect was only observed during the active phase of transcription. Chromatin immunoprecipitation with antibodies against acetylated Lys14 of H3 showed an increase in DNA recovery of the promoter regions of aa-nat, mkp-1, and c-fos after treatment with TSA. Together, our results demonstrate that histone acetylation differentially influences the transcription of adrenergic-induced genes, an enhancing effect for c-fos but inhibitory for aa-nat, mkp-1, and inducible cAMP early repressor. Moreover, both inhibitory and enhancing effects appear to be mediated through specific modification of promoter-bound histones during gene transcription.


Subject(s)
Adrenergic Agents/pharmacology , Histones/metabolism , Pineal Gland/metabolism , Transcription, Genetic/drug effects , Acetylation , Adrenergic alpha-Agonists/administration & dosage , Adrenergic alpha-Agonists/pharmacology , Animals , Arylalkylamine N-Acetyltransferase/antagonists & inhibitors , Arylalkylamine N-Acetyltransferase/genetics , Arylalkylamine N-Acetyltransferase/metabolism , Cell Cycle Proteins/genetics , Cells, Cultured , Cyclic AMP Response Element Modulator/genetics , Drug Administration Schedule , Dual Specificity Phosphatase 1 , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Histone Deacetylase Inhibitors , Hydroxamic Acids/administration & dosage , Hydroxamic Acids/pharmacology , Hydroxylamines/pharmacology , Immediate-Early Proteins/genetics , Melatonin/biosynthesis , Norepinephrine/administration & dosage , Norepinephrine/pharmacology , Phosphoprotein Phosphatases/genetics , Pineal Gland/cytology , Protein Phosphatase 1 , Protein Tyrosine Phosphatases/genetics , Proto-Oncogene Proteins c-fos/genetics , Quinolines/pharmacology , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/metabolism , Rats
10.
Endocrinology ; 148(7): 3523-31, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17446180

ABSTRACT

In this study, we investigated the transcriptional regulation of the adrenergic induction of type II iodothyronine deiodinase (Dio2) in rat pinealocytes. Treatment of pinealocytes with norepinephrine (NE) caused an increase in the mRNA level of Dio2 that peaked around 2 h and declined over the next 5 h. Both beta- and alpha1-adrenergic receptors contributed to the NE induction of Dio2 expression through a cAMP/protein kinase A mechanism. In pinealocytes that had been stimulated by NE, inhibition of transcription by actinomycin had no discernible effect on Dio2 expression. In contrast, inhibition of protein synthesis by cycloheximide enhanced the NE induction of Dio2 expression, suggesting the involvement of a repressor protein. Transient transfection of pinealocytes with adenovirus expressing small interfering RNA against Fos-related antigen 2 (Fra2) enhanced the NE induction of Dio2 expression, whereas the effect of overexpression of the full-length transcript of Fra2 was inhibitory. Time-course study indicated that preventing the NE induction of Fra2 enhanced the NE induction of Dio2 after 3 h, and the enhancement persisted beyond 6 h after NE stimulation. In comparison, transient transfection of pinealocytes with small interfering RNA against inducible cAMP early repressor (Icer) had no effect on the NE induction of Dio2 expression, whereas overexpression of the full-length transcript of Icer caused a small reduction of the NE-stimulated Dio2 expression. Together, our results support Fra-2 as an important transcriptional repressor that helps shape the time profile of the adrenergic induction of Dio2 expression in the rat pineal gland.


Subject(s)
Iodide Peroxidase/genetics , Norepinephrine/pharmacology , Pineal Gland/drug effects , Repressor Proteins/physiology , Animals , Blotting, Western , Cells, Cultured , Cyclic AMP Response Element Modulator/genetics , Cyclic AMP Response Element Modulator/metabolism , Cyclic AMP Response Element Modulator/physiology , Fos-Related Antigen-2/genetics , Fos-Related Antigen-2/metabolism , Fos-Related Antigen-2/physiology , Isoproterenol/pharmacology , Male , Phenylephrine/pharmacology , Pineal Gland/cytology , Pineal Gland/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , Rats , Rats, Sprague-Dawley , Repressor Proteins/genetics , Repressor Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Transcription, Genetic/drug effects , Transfection , Iodothyronine Deiodinase Type II
11.
Mol Cell Endocrinol ; 263(1-2): 134-41, 2007 Jan 15.
Article in English | MEDLINE | ID: mdl-17079074

ABSTRACT

We have previously shown that mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) is induced at night under the control of a photoneural system in the rat pineal gland. Because of the established roles of MAPKs, glucocorticoids and proteasome activity in regulating MKP-1 expression in other cell types, their relative contributions to MKP-1 regulation were investigated in rat pinealocytes. We found that neither inhibition of MAPKs nor treatment with dexamethasone affected norepinephrine-stimulated MKP-1 expression. In contrast, treatment with proteasome inhibitors increased norepinephrine-stimulated MKP-1 protein levels and abolished the decline in norepinephrine-stimulated MKP-1 protein levels caused by inhibition of transcription or translation, or blockade of alpha-adrenergic receptors. Taken together, our results indicate that in rat pinealocytes, the continuous and rapid turnover of MKP-1 protein allows for its rapid induction but is not sufficient to generate the sustained increase in MKP-1 expression post-adrenergic stimulation.


Subject(s)
Cell Cycle Proteins/metabolism , Immediate-Early Proteins/metabolism , Phosphoprotein Phosphatases/metabolism , Pineal Gland/metabolism , Protein Tyrosine Phosphatases/metabolism , Adrenergic alpha-Agonists/pharmacology , Animals , Blotting, Western , Cell Cycle Proteins/genetics , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Dexamethasone/pharmacology , Dual Specificity Phosphatase 1 , Glucocorticoids/pharmacology , Immediate-Early Proteins/genetics , Male , Mitogen-Activated Protein Kinases/metabolism , Norepinephrine/pharmacology , Phosphoprotein Phosphatases/genetics , Phosphorylation/drug effects , Pineal Gland/cytology , Pineal Gland/drug effects , Protein Biosynthesis/drug effects , Protein Phosphatase 1 , Protein Tyrosine Phosphatases/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Transcription, Genetic/drug effects
12.
Endocrinology ; 148(2): 743-51, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17082254

ABSTRACT

In this study, we investigated the role of two inducible repressor proteins, inducible cAMP early repressor (ICER) and Fos-related antigen 2 (Fra-2) in the adrenergic induction of MAPK phosphatase-1 (MKP-1) as compared with their roles in the induction of arylalkylamine-N-acetyltransferase (AA-NAT) in rat pinealocytes. Treatment of pinealocytes with norepinephrine (NE) caused an increase in the mRNA and protein levels of MKP-1 and AA-NAT, as well as in the AA-NAT activity and melatonin production. NE stimulation also caused a simultaneous increase in the mRNA and protein levels of ICER and Fra-2. Transient knockdown of icer using adenovirus expressing small interfering RNA (siRNA) abolished the NE induction of icer expression but had little effect on the NE induction of mkp-1 or aa-nat expression. In contrast, pretreatment with adenovirus overexpressing icer was effective in reducing the NE induction of mkp-1 and aa-nat. The inhibitory effect of overexpressing icer was reversed by cotreatment with siRNA against icer. siRNA against fra-2 also abolished the NE-stimulated expression of fra-2 but had little effect on the NE induction of mkp-1 and aa-nat expression. Proteasomal inhibition, which reduced the NE-stimulated induction of aa-nat, caused a reduction of ICER and Fra-2. Together, these results indicate that whereas overexpression of ICER can suppress the NE induction of aa-nat and mkp-1, the amount of the repressors, ICER and Fra-2, present during NE induction appears insufficient to exert a significant effect in controlling the expression of these genes.


Subject(s)
Adrenergic alpha-Agonists/pharmacology , Arylalkylamine N-Acetyltransferase/biosynthesis , Cell Cycle Proteins/biosynthesis , Cyclic AMP Response Element Modulator/physiology , Fos-Related Antigen-2/physiology , Immediate-Early Proteins/biosynthesis , Lactones/pharmacology , Norepinephrine/pharmacology , Phosphoprotein Phosphatases/biosynthesis , Pineal Gland/metabolism , Protein Tyrosine Phosphatases/biosynthesis , Animals , Cells, Cultured , Cyclic AMP Response Element Modulator/antagonists & inhibitors , Cyclic AMP Response Element Modulator/genetics , Cyclic AMP Response Element Modulator/metabolism , Dual Specificity Phosphatase 1 , Fos-Related Antigen-2/antagonists & inhibitors , Fos-Related Antigen-2/genetics , Fos-Related Antigen-2/metabolism , Gene Transfer Techniques , Male , Pineal Gland/cytology , Pineal Gland/enzymology , Proteasome Inhibitors , Protein Phosphatase 1 , RNA, Small Interfering/pharmacology , Rats , Rats, Sprague-Dawley
13.
Endocrinology ; 148(4): 1465-72, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17185373

ABSTRACT

In this study, we investigated phosphorylation of Ser10 in histone H3 by norepinephrine (NE) in the rat pineal gland. In whole-animal studies, we demonstrated a marked increase in histone H3 phosphorylation in the rat pineal gland during the first half of the dark period. Exposure to light during this period caused a rapid decline in histone H3 phosphorylation with an estimated t1/2 of less than 15 min, indicating a high level of dephosphorylation activity. Corresponding studies in cultured pineal cells revealed that treatment with NE produced an increase in histone H3 phosphorylation that peaked between 2 and 3 h and declined rapidly by 4 h. The NE-induced histone H3 phosphorylation was blocked by cotreatment with propranolol or KT5720, a protein kinase A inhibitor, but not by prazosin or other kinase inhibitors. Moreover, only treatment with dibutyryl cAMP but not other kinase activators mimicked the effect of NE on histone H3 phosphorylation. The NE-stimulated H3 phosphorylation was markedly increased by cotreatment with a serine/threonine phosphatase inhibitor, tautomycin or okadaic acid, supporting a high level of ongoing histone H3 dephosphorylation activity. Together, our results indicate that histone H3 phosphorylation is a naturally occurring event at night in the rat pineal gland that is driven almost exclusively by a NE-->beta-adrenergic-->cAMP/protein kinase A signaling mechanism. This transient histone H3 phosphorylation probably reflects the nocturnal activation of multiple adrenergic-regulated genes in the rat pineal gland.


Subject(s)
Circadian Rhythm , Cyclic AMP-Dependent Protein Kinases/metabolism , Histones/metabolism , Norepinephrine/pharmacology , Pineal Gland/metabolism , Animals , Cells, Cultured , Light , Male , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Phosphoric Monoester Hydrolases/antagonists & inhibitors , Phosphorylation , Pineal Gland/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, beta/metabolism
14.
Chronobiol Int ; 23(1-2): 361-7, 2006.
Article in English | MEDLINE | ID: mdl-16687309

ABSTRACT

In the rat pineal gland, the steady-state level of arylalkylamine N-acetyltransferase (AANAT) protein is controlled by transcriptional and translational mechanisms as well as by proteasome-mediated degradation. Studies with proteasome inhibitors, MG132 and clasto-lactacystin beta-lactone (c-lact), show two opposite effects of proteasomal inhibition on norepinephrine (NE)-induction of Aanat. Addition of MG132 or c-lact following NE stimulation causes an increase in AANAT protein level and enzyme activity without affecting the level of Aanat mRNA. In contrast, addition of inhibitors prior to NE stimulation reduces the NE-stimulated Aanat mRNA, AANAT protein, and enzyme activity. The inhibitory effect of proteasomal inhibition on adrenergic-induced Aanat transcription appears specific for Aanat because it has no effect on the adrenergic induction of mitogen-activated protein kinase phosphatase-1 (mkp-1). The effects of the proteasome inhibitors on NE-stimulated Aanat induction appear to be mediated by accumulation of a protein repressor.


Subject(s)
Arylalkylamine N-Acetyltransferase/biosynthesis , Pineal Gland/cytology , Pineal Gland/enzymology , Protease Inhibitors/pharmacology , Proteasome Inhibitors , Adrenergic Agents/metabolism , Animals , Lactones/metabolism , Leupeptins/pharmacology , Models, Biological , Rats , Time Factors
15.
Mol Cell Endocrinol ; 252(1-2): 34-9, 2006 Jun 27.
Article in English | MEDLINE | ID: mdl-16672173

ABSTRACT

Activation of members of the mitogen-activated protein kinase (MAPK) family of signaling cascades is a tightly controlled event in rat pinealocytes. Cell culture studies indicate that whereas the NE-->cGMP activation of p42/44MAPK is rapid and transient, the NE-->cAMP activation of p38MAPK is slower and more sustained. The decline in the p42/44MAPK response is in part due to the induction of MAPK phosphatase-1 by NE. In comparison, p38MAPK activation is tightly coupled to the synthesis and degradation of an upstream element in its activation cascade. Whole animal studies confirm activation of p42/44MAPK occurring during the early part of night and precedes p38MAPK activation. Studies with selective MAPK inhibitors reveal a modulating effect of MAPKs on arylalkylamine-N-acetyltransferse (AA-NAT) activity, with involvement of p42/44MAPK in the induction of AA-NAT and p38MAPK participating in the amplitude and duration of the AA-NAT response. These effects of p42/44MAPK and p38MAPK on AA-NAT activity match their timing of activation. Taken together, our studies on the timing of MAPK activation and regulation of AA-NAT by MAPKs add to the importance of MAPKs in regulating the circadian biology of the pineal gland.


Subject(s)
Mitogen-Activated Protein Kinases/metabolism , Pineal Gland/enzymology , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Arylalkylamine N-Acetyltransferase/metabolism , Enzyme Activation , Kinetics , Norepinephrine/pharmacology , Pineal Gland/physiology , Rats , Signal Transduction
16.
Biochem Pharmacol ; 70(12): 1840-50, 2005 Dec 05.
Article in English | MEDLINE | ID: mdl-16236272

ABSTRACT

Differences in the time profiles of activation between p38MAPK and p42/44MAPK by norepinephrine (NE) in rat pinealocytes suggest involvement of mechanisms other than the phosphorylation cascades in their activation. In the present study we investigated whether protein turnover played a role in regulating p38MAPK activation in the rat pineal gland. NE stimulation caused an increase in MAPK kinase3/6 (MKK 3/6) and p38MAPK phosphorylation that occurred in the absence of changes in the mRNA or protein levels of p38MAPK or MKK3/6. The stimulatory effect of NE on phosphorylated MKK3/6 and p38MAPK, but not phosphorylated p42/44MAPK, was blocked by treatment with actinomycin or cycloheximide, indicating a requirement of transcription and translation in activation of the p38MAPK but not the p42/44MAPK pathway. Moreover, inhibition of proteasomes by clasto-lactacystin beta-lactone or Z-Leu-Leu-Leu-CHO (MG132) selectively increased basal and NE-stimulated phosphorylated MKK3/6 and p38MAPK levels without affecting the mRNA or protein levels of MKK3 or p38MAPK. In contrast, the effect of proteasomal inhibition on NE-stimulated p42/44MAPK phosphorylation was inhibitory. Treatment with MG132 also reduced the decline in the phosphorylated levels of NE-stimulated MKK3/6 and p38MAPK that normally follows beta-adrenergic blockade. Together, our results indicate that p38MAPK but not p42/44MAPK activation in the rat pineal gland is tightly coupled to protein synthesis and degradation. The synthesis of an activator upstream of MKK3/6 is required for the NE-activation of p38MAPK.


Subject(s)
Pineal Gland/enzymology , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Cycloheximide/pharmacology , Dactinomycin/pharmacology , Enzyme Activation , Leupeptins/pharmacology , MAP Kinase Kinase 3/metabolism , MAP Kinase Signaling System , Male , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Norepinephrine/pharmacology , Phosphorylation , Pineal Gland/cytology , Proteasome Endopeptidase Complex/physiology , Rats , Rats, Sprague-Dawley
17.
Endocrinology ; 145(11): 5194-201, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15297444

ABSTRACT

In this study, we investigated adrenergic and photoneural regulation of p38MAPK phosphorylation in the rat pineal gland. Norepinephrine (NE), the endogenous neurotransmitter, dose-dependently increased the levels of phosphorylated MAPK kinase 3/6 (MKK3/6) and p38MAPK in rat pinealocytes. Time-course studies showed a gradual increase in MKK3/6 and p38MAPK phosphorylation that peaked between 1 and 2 h and persisted for 4 h post NE stimulation. In cells treated with NE for 2 and 4 h, the inclusion of prazosin or propranolol reduced NE-induced MKK3/6 and p38MAPK phosphorylation, indicating involvement of both alpha- and beta-adrenergic receptors for the sustained response. Whereas treatment with dibutyryl cAMP or ionomycin mimicked the NE-induced MKK3/6 and p38MAPK phosphorylation, neither dibutyryl cGMP nor 4beta-phorbol 12-myristate 13-acetate had an effect. The NE-induced increase in MKK3/6 and p38MAPK phosphorylation was blocked by KT5720 (a protein kinase A inhibitor) and KN93 (a Ca(2+)/calmodulin-dependent kinase inhibitor), but not by KT5823 (a protein kinase G inhibitor) or calphostin C (a protein kinase C inhibitor). In animals housed under a lighting regimen with 12 h of light, MKK3/6 and p38MAPK phosphorylation increased in the rat pineal gland at zeitgeber time 18. The nocturnal increase in p38MAPK phosphorylation was blocked by exposing the animal to constant light and reduced by treatment with propranolol, a beta-adrenergic blocker. Together, our results indicate that activation of p38MAPK is under photoneural control in the rat pineal gland and that protein kinase A and intracellular Ca(2+) signaling pathways are involved in NE regulation of p38MAPK.


Subject(s)
Circadian Rhythm/physiology , Norepinephrine/pharmacology , Pineal Gland/metabolism , Sympathomimetics/pharmacology , p38 Mitogen-Activated Protein Kinases/metabolism , Adrenergic Antagonists/pharmacology , Adrenergic beta-Agonists/pharmacology , Animals , Cells, Cultured , Circadian Rhythm/drug effects , Lighting , MAP Kinase Kinase 3/metabolism , MAP Kinase Kinase 6/metabolism , Male , Phosphorylation , Pineal Gland/cytology , Propranolol/pharmacology , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Signal Transduction/physiology
18.
Mol Cell Endocrinol ; 218(1-2): 175-83, 2004 Apr 15.
Article in English | MEDLINE | ID: mdl-15130522

ABSTRACT

In this study, we investigated the effect of ceramide on the L-type Ca2+ channel (L-channel) in GH3 cells. We found that C6-ceramide, but not C6-dihydroceramide, the inactive analogue, had an inhibitory effect on BayK 8644-stimulated GH release. Using patch clamp analysis, C6- and C2-ceramide, but not C6-dihydroceramide, were found to inhibit the L-channel current. Increasing intracellular ceramide level with sphingomyelinase also inhibited the L-channel current. The inhibitory effect of ceramide on the L-channel current was attenuated by calphostin C, a myristolated pseudosubstrate protein kinase C (PKC) inhibitor, and lavendustin A, a tyrosine kinase inhibitor. Combined treatment with lavendustin A and the myristolated PKC inhibitor blocked the effect of ceramide on the L-channel current. These results indicate that ceramide, a lipid messenger of the sphingomyelin pathway, is an important regulator of the L-channel in GH3 cells and both tyrosine kinase and PKC are involved in this effect of ceramide.


Subject(s)
Calcium Channel Blockers/metabolism , Calcium Channels, L-Type/metabolism , Ceramides/metabolism , 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/metabolism , Animals , Calcium/metabolism , Calcium Channel Agonists/metabolism , Cell Line , Ceramides/chemistry , Electrophysiology , Enzyme Inhibitors/metabolism , Naphthalenes/metabolism , Phenols/metabolism , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Rats , Second Messenger Systems/physiology , Sphingomyelin Phosphodiesterase/metabolism , Tetradecanoylphorbol Acetate/metabolism
19.
Endocrinology ; 145(3): 1167-74, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14617573

ABSTRACT

We have previously shown that inhibition of p38(MAPK) increases adrenergic-stimulated p42/44(MAPK) activation in rat pinealocytes. In this study we investigated whether p38(MAPK) played a role in the adrenergic regulation of arylalkylamine-N-acetyltransferase (AA-NAT) induction and melatonin (MT) synthesis. Treatment of pinealocytes with norepinephrine (NE) caused a time-dependent increase in the levels of AA-NAT mRNA, AA-NAT protein, and enzymatic activity as well as MT production. Cotreatment with SB202190, a selective p38(MAPK) inhibitor, although having no effect on AA-NAT activity or protein level 3 h after NE treatment, caused a sustained increase in AA-NAT activity and protein level after 6 h of NE treatment. The increases in NE-stimulated AA-NAT activity and protein level by SB202190 occurred in the absence of an increase in AA-NAT mRNA. Similar results were obtained when AA-NAT was induced by (Bu)(2)cAMP or when SB203580 was used to inhibit p38(MAPK). In comparison, SB202474, the inactive analog, had no effect on NE or (Bu)(2)cAMP-stimulated AA-NAT activity or protein level. SB202190 also increased cumulative NE-stimulated MT production, provided that the medium was supplemented with 5-methoxytryptamine. p38(MAPK) inhibitors had no effect on hydroxyindole-O-methyltransferase activity. These results show that inhibition of p38(MAPK), although having no effect on cAMP-mediated AA-NAT transcription, appears to increase AA-NAT activity either by increasing translation or by reducing degradation of the AA-NAT protein. The lack of effect on NE-stimulated MT accumulation by p38(MAPK) inhibitors in the absence of 5-methoxytryptamine could be secondary to a lack of substrate, or alternatively, hydroxyindole-O-methyltransferase may become limiting.


Subject(s)
Arylamine N-Acetyltransferase/metabolism , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Pineal Gland/enzymology , Acetylserotonin O-Methyltransferase/metabolism , Animals , Arylamine N-Acetyltransferase/genetics , Bucladesine/pharmacology , Enzyme Activation/drug effects , Enzyme Induction/physiology , Enzyme Inhibitors/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Imidazoles/pharmacology , Male , Melatonin/biosynthesis , Melatonin/metabolism , Mitogen-Activated Protein Kinases/metabolism , Norepinephrine/pharmacology , Pineal Gland/cytology , Pyridines/pharmacology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Sympathomimetics/pharmacology , p38 Mitogen-Activated Protein Kinases
20.
Mol Cell Endocrinol ; 208(1-2): 23-30, 2003 Oct 31.
Article in English | MEDLINE | ID: mdl-14580718

ABSTRACT

In this study, we investigated whether there was a diurnal difference in mitogen-activated protein kinase (p42/44(MAPK)) phosphorylation in the rat pineal gland. Under a lighting regimen with 12h of darkness, there was a two- to four-fold increase in phosphorylated levels of MAPK kinase 1/2 (MEK1/2) and p42/44(MAPK) 2h after onset of darkness, an increase that was sustained for 8h. The increases in phosphorylated levels of MEK1/2 and p42/44(MAPK) occurred without increases in MEK1/2 and p42/44(MAPK) proteins. When rats were treated with propranolol 1h before onset of darkness or subjected to continuous light exposure during the dark phase, the nocturnal increase in MEK1/2 and p42/44(MAPK) phosphorylation was reduced. Acute light exposure during darkness caused a decline in MEK1/2 and p42/44(MAPK) phosphorylation within 30 min of light exposure. These results indicate the presence of a diurnal difference in MEK1/2 and p42/44(MAPK) phosphorylation in the rat pineal gland that is under adrenergic control.


Subject(s)
Circadian Rhythm , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinases/metabolism , Pineal Gland/enzymology , Animals , Arylamine N-Acetyltransferase/metabolism , Light , Mitogen-Activated Protein Kinase 1/analysis , Mitogen-Activated Protein Kinase 3 , Propranolol/pharmacology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...